See All Slides - tctmd.com

Slides

Presentation TCT 2012

Gene Therapy for Peripheral Arterial Disease: Status Update

Presenter: Timothy Henry

October 22, 2012

Presentation TCT 2012

The Italian TAVR Registry

Presenter: Anna Sonia Petronio

October 22, 2012

Presentation TCT 2012

The SOURCE Multicenter EU Registries (Including XT)

Presenter: Martyn Thomas

October 22, 2012

Presentation TCT 2012

Clinical Outcomes and Complications

Presenter: Martin Leon

October 22, 2012

Presentation

Urgent Invasive Strategy for Out-of-Hospital Cardiac Arrest Survivors Is Associated with Better Survival

Presenter: Annamaria Nicolino

October 22, 2012

Presentation TCT 2012

European Perspectives(3)

Presenter: Hans Figulla

October 22, 2012

Presentation TCT 2012

Morphology and Distribution of Left Main and Non-Left Main Bifurcation Atherosclerosis: What's Different, and Does It Matter?

Presenter: Akiko Maehara

October 22, 2012

Presentation TCT 2012

Use and Utility of IVUS During Left Main Stenting

Presenter: Gary Mintz

October 22, 2012

Presentation TCT 2012

What Can We Learn from Novel CTO Models?

Presenter: Greg Kaluza

October 22, 2012

Presentation TCT 2012

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Presenter: John Webb

October 22, 2012

Advertisement

Slides

Gene Therapy for Peripheral Arterial Disease: Status Update

The Italian TAVR Registry

The SOURCE Multicenter EU Registries (Including XT)

Clinical Outcomes and Complications

Urgent Invasive Strategy for Out-of-Hospital Cardiac Arrest Survivors Is Associated with Better Survival

European Perspectives(3)

Morphology and Distribution of Left Main and Non-Left Main Bifurcation Atherosclerosis: What's Different, and Does It Matter?

Use and Utility of IVUS During Left Main Stenting

What Can We Learn from Novel CTO Models?

Improved Patient Screening, Meticulous Access and Closure Techniques, and Lower Profile Catheter Systems Can Reduce Major Vascular Complications to <5%: The Vancouver Experience

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content